- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
A renal nurse complained that Durogesic DTrans branded pens were in BRS 2013 delegate bags. Panel found a…
MIMS “abbreviated” CosmoCol ad included pack size/cost and other claims, so needed prescribing info. Both the ad and…
Flynn sent a “Dear Doctor” letter during an Equasym supply shortage, promoting Medikinet/Medikinet XL. Panel found no issue…
A health professional alleged multiple Pfizer website items had out-of-date prescribing information. Breaches were found for Vfend and…
A GP challenged an Acomplia claim that ~50% of improvements in cardiometabolic risk factors were beyond weight loss.…
PCT prescribing advisor challenged a Bonviva leavepiece using 62% vertebral fracture reduction data from a 2.5mg daily study…
A public complaint about clinical trial disclosure for Lyxumia was ruled outwith the scope of the ABPI Code…
A GP complained that a Cipralex cost bar chart implied generic competitor prices but actually used branded prices.…
A complaint about a Novartis tweet relating to liver disease. The PMCPA concluded no breach because the matter…
Anonymous ex-employee alleged an online trade-journal interview promoted unlicensed medicines to the public. Panel found PME targeted pharma…
One real case. One key lesson. Every week — free.